LRNZ - ETF AI Analysis
Top Page
TrueShares Technology, AI & Deep Learning ETF (LRNZ)
LRNZ, the TrueShares Technology, AI & Deep Learning ETF, earns a solid overall rating thanks to several strong, growth-focused holdings like MongoDB, Palo Alto Networks, Datadog, CrowdStrike, and Samsara, which benefit from robust financial performance, positive earnings sentiment, and strategic positioning in AI and security. These strengths are partly offset by weaker names such as Schrodinger and some holdings with ongoing profitability and valuation challenges, and the fund’s heavy focus on technology and AI-related companies means investors face concentrated sector risk if sentiment or fundamentals in this area weaken.
LRNZ vs. SPDR S&P 500 ETF (SPY)
- AUM
- 41.10M
- Region
- North America
- Expense Ratio
- 0.69%
- Beta
- 1.54
- Issuer
- TrueShares
- Inception Date
- Feb 28, 2020
- Dividend Yield
- 0.11%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
LRNZ Summary
LRNZ is the TrueShares Technology, AI & Deep Learning ETF, focused on companies using artificial intelligence, deep learning, and robotics rather than tracking a traditional index. It mainly holds U.S. technology and health care firms that rely heavily on data and software, such as well-known names like Cloudflare and CrowdStrike. Investors might consider LRNZ if they want growth potential from cutting-edge tech and a way to spread their money across many AI-related companies instead of picking just one stock. A key risk is that it is heavily concentrated in technology and can go up or down sharply with swings in that sector.
How much will it cost me?
This ETF has an expense ratio of 0.69%, which means you’ll pay about $6.90 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed and focused on a specialized area of technology, AI, and deep learning.
What would affect this ETF?
This ETF is heavily focused on U.S. technology and AI-related companies like Cloudflare, CrowdStrike, and Snowflake, so it could benefit from growing demand for cloud computing, cybersecurity, and AI tools, as well as supportive regulations and business investment in automation and data analytics. On the downside, it may be hurt by rising interest rates that pressure high-growth tech valuations, tighter rules around data and AI use, or an economic slowdown that reduces spending on advanced software and health care innovation.
LRNZ Top 10 Holdings
LRNZ is leaning hard into U.S. AI and cloud infrastructure, with cybersecurity and data platforms doing most of the heavy lifting. CrowdStrike, Palo Alto Networks, and Datadog have been rising, acting like the fund’s digital bodyguards and key performance engines. Natera and Guardant Health add a fast-growing health-tech twist, also contributing positively. On the softer side, Cloudflare and Snowflake have seen more mixed, recently lagging action, occasionally tugging on returns. Overall, it’s a tech-heavy, AI-first portfolio with meaningful exposure to data, security, and next-gen healthcare innovation.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Natera | 8.00% | $3.15M | $59.72B | 90.48% | 73Outperform | |
| CrowdStrike Holdings | 7.21% | $2.84M | $256.42B | 78.13% | 67Neutral | |
| Cloudflare | 6.63% | $2.61M | $99.95B | 4.69% | 61Neutral | |
| Guardant Health | 5.59% | $2.20M | $23.99B | 83.54% | 61Neutral | |
| Snowflake | 5.49% | $2.16M | $107.99B | 5.75% | 54Neutral | |
| Palo Alto Networks | 5.09% | $2.00M | $299.56B | 59.70% | 73Outperform | |
| Schrodinger | 5.03% | $1.98M | $2.03B | 24.48% | 44Neutral | |
| Samsara | 4.84% | $1.90M | $24.64B | 4.31% | 69Neutral | |
| MongoDB | 4.30% | $1.69M | $28.43B | -8.17% | 75Outperform | |
| Datadog | 4.02% | $1.58M | $84.48B | 32.73% | 69Neutral |
LRNZ Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For LRNZ, the sentiment is Negative. The current price of 58.67 is below the 20-day moving average (MA) of 64.43, below the 50-day MA of 64.70, and above the 200-day MA of 54.48, indicating a neutral trend. The MACD of -1.08 indicates Positive momentum. The RSI at 36.20 is Neutral, neither overbought nor oversold. The STOCH value of 29.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LRNZ.
LRNZ Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $58.67 | $66.00(12.49% Upside) | $41.10M | 0.69% | 66Neutral | |
| $24.54 | $31.38(27.85% Upside) | $45.24M | 0.35% | 68Neutral | |
| $23.76 | $31.89(34.23% Upside) | $43.33M | 0.88% | 75Outperform | |
| $22.80 | $33.82(48.37% Upside) | $43.07M | 0.65% | 68Neutral | |
| $20.39 | $37.04(81.64% Upside) | $33.75M | 0.59% | 64Neutral | |
| $24.46 | $34.17(39.72% Upside) | $4.96M | 0.88% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| LRNZ | TrueShares Technology, AI & Deep Learning ETF | 58.67 | 8.16 | 16.15% | |
| CCSO | Carbon Collective Climate Solutions U.S. Equity ETF | 24.54 | -0.06 | -0.25% | |
| TMGN | TappAlpha Cboe Magnificent 10 Growth & Daily Income ETF | 23.76 | 0.64 | 2.76% | |
| BUIL | Rebuild America ETF | 22.80 | -2.06 | -8.31% | |
| ANTW | Anthropic AI Lab Ecosystem ETF | 20.39 | -4.63 | -18.52% | |
| EPAI | Harbor AI Inflection Strategy ETF | 24.46 | 4.69 | 23.75% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.